![](/img/cover-not-exists.png)
Antitumor effects of endocrine treatment of mammary tumor bearing rats with combinations of the antiprogestin mifepristone (RU486) and LHRH-analogs (buserelin or zoladex) or tamoxifen
G.H. Bakker, B. Setyono-Han, J.G.M. KlijnVolume:
28
Year:
1987
Language:
english
DOI:
10.1016/0022-4731(87)91529-9
File:
PDF, 116 KB
english, 1987